Groggel G C, Adler S, Rennke H G, Couser W G, Salant D J
J Clin Invest. 1983 Dec;72(6):1948-57. doi: 10.1172/JCI111159.
Our recent observations of a complement-mediated, cell-independent mechanism of altered glomerular permeability in rat membranous nephropathy suggested a possible role for the terminal complement pathway in the mediation of proteinuria in certain forms of glomerular disease. To directly determine whether the membranolytic terminal complement components (C5b-C9) are involved in glomerular injury, we studied the development of proteinuria in normal and C6-deficient (C6D) rabbits, in both of which a membranous nephropathy-like lesion develops early in the course of immunization with cationized bovine serum albumin (cBSA) (pI 8.9-9.2). C6 hemolytic activity of C6D was 0.01% that of control rabbits. After 1 wk of daily intravenous injections of cBSA, proteinuria developed in 71% of controls (median 154, range 1-3,010 mg/24 h, n = 24), whereas none of C6D were proteinuric (median 6, range 2-12 mg/24 h, n = 12, P less than 0.01). After 1 wk of cBSA, both groups had qualitatively identical glomerular deposits of BSA, rabbit IgG, and C3 on immunofluorescence microscopy, predominantly subepithelial electron-dense deposits on electron microscopy, and minimal glomerular inflammatory cell infiltration of glomeruli. Glomeruli were isolated from individual animals after 1 wk of cBSA and deposits of rabbit IgG antibody were quantitated by a standardized in vitro assay using anti-rabbit IgG-125I. Rabbit IgG deposits were found to be similar in control (29.8 +/- 13.2, range 12.7-48.6 micrograms anti-IgG/2,000 glomeruli, n = 6) and C6D rabbits (32.6 +/- 13.8, range 16.8-48.8 micrograms anti-IgG/2,000 glomeruli, n = 5, P greater than 0.05). After 2 wk, coincident with a prominent influx of mononuclear cells and neutrophils, proteinuria developed in C6D rabbits. These results document, for the first time, a requirement for a terminal complement component in the development of immunologic glomerular injury. Since the only known action of C6 is in the assembly of the membrane attack complex, these observations suggest that the membranolytic properties of complement may contribute to glomerular damage.
我们最近对大鼠膜性肾病中补体介导的、不依赖细胞的肾小球通透性改变机制的观察表明,终末补体途径在某些形式的肾小球疾病蛋白尿的介导中可能发挥作用。为了直接确定膜溶解终末补体成分(C5b - C9)是否参与肾小球损伤,我们研究了正常兔和C6缺陷(C6D)兔蛋白尿的发展情况,在这两种兔中,用阳离子化牛血清白蛋白(cBSA)(pI 8.9 - 9.2)免疫过程早期都会出现类似膜性肾病的病变。C6D兔的C6溶血活性为对照兔的0.01%。每日静脉注射cBSA 1周后,71%的对照兔出现蛋白尿(中位数154,范围1 - 3,010 mg/24 h,n = 24),而C6D兔均无蛋白尿(中位数6,范围2 - 12 mg/24 h,n = 12,P < 0.01)。注射cBSA 1周后,两组在免疫荧光显微镜下肾小球内BSA、兔IgG和C3的沉积在性质上相同,电镜下主要为上皮下电子致密沉积物,肾小球内炎性细胞浸润极少。注射cBSA 1周后从个体动物分离肾小球,并用抗兔IgG - 125I的标准化体外试验对兔IgG抗体沉积进行定量。发现对照兔(29.8 ± 13.2,范围12.7 - 48.6微克抗IgG/2,000个肾小球,n = 6)和C6D兔(32.6 ± 13.8,范围16.8 - 48.8微克抗IgG/2,000个肾小球,n = 5,P > 0.05)的兔IgG沉积相似。2周后,与单核细胞和中性粒细胞的大量涌入同时发生,C6D兔出现蛋白尿。这些结果首次证明了终末补体成分在免疫性肾小球损伤发展中的必要性。由于C6的唯一已知作用是参与膜攻击复合物的组装,这些观察结果表明补体的膜溶解特性可能导致肾小球损伤。